The contemporary management of peritoneal metastasis: A journey from the cold past of treatment futility to a warm present and a bright future
Author:
Affiliation:
1. Division of Surgical Oncology, Department of Surgery University of Nebraska Medical Center Omaha Nebraska USA
2. Division of Surgical Oncology Rutgers Cancer Institute of New Jersey
Publisher
Wiley
Subject
Oncology,Hematology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.3322/caac.21749
Reference199 articles.
1. The incidence of mucinous appendiceal malignancies: a population-based study
2. Appendiceal neoplasms and pseudomyxoma peritonei: A population based study
3. Complete Cytoreduction for Pseudomyxoma Peritonei Is Optimal but Maximal Tumor Debulking May Be Beneficial in Patients in Whom Complete Tumor Removal Cannot Be Achieved
4. Epidemiology of mesothelioma in the 21st century in Europe and the United States, 40 years after restricted/banned asbestos use
5. American Society of Clinical Oncology (ASCO) Cancer.Net. Mesothelioma: Statistics. ASCO; 2021. Accessed February 14 2022.cancer.net/cancer‐types/mesothelioma/statistics
Cited by 37 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The anti-cancer mechanism of Celastrol by targeting JAK2/STAT3 signaling pathway in gastric and ovarian cancer;Toxicology and Applied Pharmacology;2024-10
2. Prognostic factors of early recurrence after complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy;World Journal of Clinical Cases;2024-09-26
3. Survival Outcomes of Cytoreductive Surgery with HIPEC in Gastric Adenocarcinoma: A National Cancer Database Study;Annals of Surgical Oncology;2024-09-05
4. Correlation of Morphological Appearance of Peritoneal Lesions at Laparotomy and Disease at Pathological Assessment in Patients Undergoing Cytoreductive Surgery for Peritoneal Malignancy: Results of Phase I of the PRECINCT Study in 707 Patients;Annals of Surgical Oncology;2024-08-26
5. Single-cell transcriptome analysis revealed heterogeneity in glycolysis and identified IGF2 as a therapeutic target for ovarian cancer subtypes;BMC Cancer;2024-07-31
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3